- Home
- MAMA vs JSPR Comparison
MAMA vs JSPR Comparison
Compare MAMA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAMA | JSPR |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | United States | United States |
| Employees | N/A | 22 |
| Industry | Specialty Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 548.5M | 23.1M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | MAMA | JSPR |
|---|---|---|
| Price | $15.37 | $0.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $19.00 | $15.50 |
| AVG Volume (30 Days) | ★ 316.3K | 243.2K |
| Earning Date | 04-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $95,420,129.00 | N/A |
| Revenue This Year | $31.09 | N/A |
| Revenue Next Year | $16.12 | N/A |
| P/E Ratio | $117.85 | ★ N/A |
| Revenue Growth | ★ 95.54 | N/A |
| 52 Week Low | $6.84 | $0.62 |
| 52 Week High | $17.85 | $7.19 |
Technical Indicators
Market Signals| Indicator | MAMA | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 44.24 |
| Support Level | $15.36 | $0.81 |
| Resistance Level | $16.75 | $1.03 |
| Average True Range (ATR) | 0.64 | 0.07 |
| MACD | 0.25 | -0.01 |
| Stochastic Oscillator | 90.81 | 36.67 |
Price Performance
Historical ComparisonAbout MAMA Mama's Creations Inc.
Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.